Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs AM Rx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AM Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 545 · Grade C

AM Rx

Visit AM Rx Full brief →

FDA warning letter, June 2026 — issued to FitRX, LLC dba AM RX. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 39 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make AM Rx a bad call — it's best for readers comparing a quarterly cash-pay offer with insurance assistance. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
32
Supply Reliability
95
59
Transparency
90
24
Access Breadth
93
46
Clinical Oversight
92
47
Track Record
88
25
CoreAge RxBrief Score 94 · 39AM Rx

Price, coverage & the tracker

CoreAge RxAM Rx
Brief Score94/100 (A)39/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Advertised from $106/mo when purchased quarterly. Confirm fees.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Request a plan-specific quote.

CoverageUS only; restrictions by state, confirmed at intakeConfirm availability with AM Rx for the selected treatment.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

AM Rx: Ask for the full quarterly charge and separate membership fees.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.